# BIO-RAD LABORATORIES, INC. (BIO) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from BIO-RAD LABORATORIES, INC.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/BIO/mda/fy2025/): filed 2026-02-13; accession 0000012208-26-000010 (https://www.sec.gov/Archives/edgar/data/12208/000001220826000010/bio-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/BIO/mda/fy2024/): filed 2025-02-14; accession 0000012208-25-000007 (https://www.sec.gov/Archives/edgar/data/12208/000001220825000007/bio-20241231.htm)
- [FY 2023 MD&A](/company/BIO/mda/fy2023/): filed 2024-02-16; accession 0000012208-24-000013 (https://www.sec.gov/Archives/edgar/data/12208/000001220824000013/bio-20231231.htm)
- [FY 2022 MD&A](/company/BIO/mda/fy2022/): filed 2023-02-17; accession 0000012208-23-000031 (https://www.sec.gov/Archives/edgar/data/12208/000001220823000031/bio-20221231.htm)
- [FY 2021 MD&A](/company/BIO/mda/fy2021/): filed 2022-02-11; accession 0000012208-22-000011 (https://www.sec.gov/Archives/edgar/data/12208/000001220822000011/bio-20211231.htm)

Back to /company/BIO/